BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 21442160)

  • 1. Increasing skeletal muscle fatty acid transport protein 1 (FATP1) targets fatty acids to oxidation and does not predispose mice to diet-induced insulin resistance.
    Holloway GP; Chou CJ; Lally J; Stellingwerff T; Maher AC; Gavrilova O; Haluzik M; Alkhateeb H; Reitman ML; Bonen A
    Diabetologia; 2011 Jun; 54(6):1457-67. PubMed ID: 21442160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid transport protein 1 (FATP1) localizes in mitochondria in mouse skeletal muscle and regulates lipid and ketone body disposal.
    Guitart M; Osorio-Conles O; Pentinat T; Cebrià J; García-Villoria J; Sala D; Sebastián D; Zorzano A; Ribes A; Jiménez-Chillarón JC; García-Martínez C; Gómez-Foix AM
    PLoS One; 2014; 9(5):e98109. PubMed ID: 24858472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac and skeletal muscle fatty acid transport and transporters and triacylglycerol and fatty acid oxidation in lean and Zucker diabetic fatty rats.
    Bonen A; Holloway GP; Tandon NN; Han XX; McFarlan J; Glatz JF; Luiken JJ
    Am J Physiol Regul Integr Comp Physiol; 2009 Oct; 297(4):R1202-12. PubMed ID: 19675275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation.
    Holloway GP; Benton CR; Mullen KL; Yoshida Y; Snook LA; Han XX; Glatz JF; Luiken JJ; Lally J; Dyck DJ; Bonen A
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E738-47. PubMed ID: 19141681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Greater transport efficiencies of the membrane fatty acid transporters FAT/CD36 and FATP4 compared with FABPpm and FATP1 and differential effects on fatty acid esterification and oxidation in rat skeletal muscle.
    Nickerson JG; Alkhateeb H; Benton CR; Lally J; Nickerson J; Han XX; Wilson MH; Jain SS; Snook LA; Glatz JFC; Chabowski A; Luiken JJFP; Bonen A
    J Biol Chem; 2009 Jun; 284(24):16522-16530. PubMed ID: 19380575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In obese Zucker rats, lipids accumulate in the heart despite normal mitochondrial content, morphology and long-chain fatty acid oxidation.
    Holloway GP; Snook LA; Harris RJ; Glatz JF; Luiken JJ; Bonen A
    J Physiol; 2011 Jan; 589(Pt 1):169-80. PubMed ID: 21041527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PGC-1alpha) improve lipid utilisation, insulin signalling and glucose transport in skeletal muscle of lean and insulin-resistant obese Zucker rats.
    Benton CR; Holloway GP; Han XX; Yoshida Y; Snook LA; Lally J; Glatz JF; Luiken JJ; Chabowski A; Bonen A
    Diabetologia; 2010 Sep; 53(9):2008-19. PubMed ID: 20490453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extremely rapid increase in fatty acid transport and intramyocellular lipid accumulation but markedly delayed insulin resistance after high fat feeding in rats.
    Bonen A; Jain SS; Snook LA; Han XX; Yoshida Y; Buddo KH; Lally JS; Pask ED; Paglialunga S; Beaudoin MS; Glatz JF; Luiken JJ; Harasim E; Wright DC; Chabowski A; Holloway GP
    Diabetologia; 2015 Oct; 58(10):2381-91. PubMed ID: 26197708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36.
    Bonen A; Parolin ML; Steinberg GR; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ; Dyck DJ
    FASEB J; 2004 Jul; 18(10):1144-6. PubMed ID: 15132977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism.
    Bonen A; Han XX; Habets DD; Febbraio M; Glatz JF; Luiken JJ
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1740-9. PubMed ID: 17264223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased fatty acid uptake and altered fatty acid metabolism in insulin-resistant muscle of obese Zucker rats.
    Turcotte LP; Swenberger JR; Zavitz Tucker M; Yee AJ
    Diabetes; 2001 Jun; 50(6):1389-96. PubMed ID: 11375340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites.
    Lee JS; Pinnamaneni SK; Eo SJ; Cho IH; Pyo JH; Kim CK; Sinclair AJ; Febbraio MA; Watt MJ
    J Appl Physiol (1985); 2006 May; 100(5):1467-74. PubMed ID: 16357064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats.
    Coort SL; Hasselbaink DM; Koonen DP; Willems J; Coumans WA; Chabowski A; van der Vusse GJ; Bonen A; Glatz JF; Luiken JJ
    Diabetes; 2004 Jul; 53(7):1655-63. PubMed ID: 15220187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of muscle mitochondrial oxidative capacity and alterations in insulin action are lipid species dependent: potent tissue-specific effects of medium-chain fatty acids.
    Turner N; Hariharan K; TidAng J; Frangioudakis G; Beale SM; Wright LE; Zeng XY; Leslie SJ; Li JY; Kraegen EW; Cooney GJ; Ye JM
    Diabetes; 2009 Nov; 58(11):2547-54. PubMed ID: 19720794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoring AS160 phosphorylation rescues skeletal muscle insulin resistance and fatty acid oxidation while not reducing intramuscular lipids.
    Alkhateeb H; Chabowski A; Glatz JF; Gurd B; Luiken JJ; Bonen A
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1056-66. PubMed ID: 19724017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel role of FATP1 in mitochondrial fatty acid oxidation in skeletal muscle cells.
    Sebastián D; Guitart M; García-Martínez C; Mauvezin C; Orellana-Gavaldà JM; Serra D; Gómez-Foix AM; Hegardt FG; Asins G
    J Lipid Res; 2009 Sep; 50(9):1789-99. PubMed ID: 19429947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women.
    Holloway GP; Thrush AB; Heigenhauser GJ; Tandon NN; Dyck DJ; Bonen A; Spriet LL
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1782-9. PubMed ID: 17311893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid binding protein facilitates sarcolemmal fatty acid transport but not mitochondrial oxidation in rat and human skeletal muscle.
    Holloway GP; Lally J; Nickerson JG; Alkhateeb H; Snook LA; Heigenhauser GJ; Calles-Escandon J; Glatz JF; Luiken JJ; Spriet LL; Bonen A
    J Physiol; 2007 Jul; 582(Pt 1):393-405. PubMed ID: 17478525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced fatty acid oxidation and FATP4 protein expression after endurance exercise training in human skeletal muscle.
    Jeppesen J; Jordy AB; Sjøberg KA; Füllekrug J; Stahl A; Nybo L; Kiens B
    PLoS One; 2012; 7(1):e29391. PubMed ID: 22235293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acid transport proteins chronically relocate to the transverse-tubules in muscle from obese Zucker rats but are resistant to further insulin-induced translocation.
    Stefanyk LE; Bonen A; Dyck DJ
    Metabolism; 2013 Sep; 62(9):1296-304. PubMed ID: 23743348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.